 Connection
Bradley Warady to Erythropoietin
This is a "connection" page, showing publications Bradley Warady has written about Erythropoietin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.316 |
|
|
|
-
Warady BA, Meyer Reigner S, Tirodkar C, Drozdz D. Subcutaneous C.E.R.A. for the Maintenance Treatment of?Anemia in Pediatric Patients With CKD: A Phase 2, Open-Label, Single-Arm, Multicenter Study. Am J Kidney Dis. 2023 06; 81(6):684-694.e1.
Score: 0.901
-
Warady BA, Arar MY, Lerner G, Nakanishi AM, Stehman-Breen C. Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease. Pediatr Nephrol. 2006 Aug; 21(8):1144-52.
Score: 0.285
-
Kohlhas L, Studer M, Rutten-Jacobs L, Reigner SM, Sander A, Yap HK, Vondrak K, Coccia PA, Cano F, Schmitt CP, Warady BA, Schaefer F. Real-world evidence on the dosing and safety of C.E.R.A. in pediatric dialysis patients: findings from the International Pediatric Dialysis Network registries. Pediatr Nephrol. 2024 Mar; 39(3):807-818.
Score: 0.235
-
Chanu P, Schaefer F, Warady BA, Schmitt CP, Reigner B, Schnetzler G, Meyer Reigner S, Eisner M, Weichert A, Frey N. Model-based approach for methoxy polyethylene glycol-epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease. Br J Clin Pharmacol. 2020 04; 86(4):801-811.
Score: 0.184
-
Warady BA, Jabs K. New hormones in the therapeutic arsenal of chronic renal failure. Growth hormone and erythropoietin. Pediatr Clin North Am. 1995 Dec; 42(6):1551-77.
Score: 0.138
-
Warady BA, Sabath RJ, Smith CA, Alon U, Hellerstein S. Recombinant human erythropoietin therapy in pediatric patients receiving long-term peritoneal dialysis. Pediatr Nephrol. 1991 Nov; 5(6):718-23.
Score: 0.104
-
Warady BA. Recombinant human erythropoietin: duplicate publication. Pediatr Nephrol. 1991 Nov; 5(6):763.
Score: 0.104
-
Warady BA, Zobrist RH, Wu J, Finan E. Sodium ferric gluconate complex therapy in anemic children on hemodialysis. Pediatr Nephrol. 2005 Sep; 20(9):1320-7.
Score: 0.067
-
Warady BA, Kausz A, Lerner G, Brewer ED, Chadha V, Brugnara C, Dahl NV, Watkins SL. Iron therapy in the pediatric hemodialysis population. Pediatr Nephrol. 2004 Jun; 19(6):655-61.
Score: 0.061
-
Frankenfield DL, Neu AM, Warady BA, Fivush BA, Johnson CA, Brem AS. Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project. Kidney Int. 2003 Sep; 64(3):1120-4.
Score: 0.059
-
Warady B, Watkins SL. Current advances in the therapy of chronic renal failure and end stage renal disease. Semin Nephrol. 1998 May; 18(3):341-54.
Score: 0.041
-
Schwartz ID, Warady BA, Reddig N, Meek K. Elevated glycosylated hemoglobin in a patient receiving recombinant erythropoietin. Pediatr Nephrol. 1996 Dec; 10(6):809-10.
Score: 0.037
-
Alon US, Allen S, Rameriz Z, Warady BA, Kaplan RA, Harris DJ. Lidocaine for the alleviation of pain associated with subcutaneous erythropoietin injection. J Am Soc Nephrol. 1994 Oct; 5(4):1161-2.
Score: 0.032
-
Kaplan RA, Allen S, Warady BA, Alon US. Effect of lidocaine on the hematopoietic properties of recombinant human erythropoietin in the uremic rat. Pediatr Nephrol. 1994 Aug; 8(4):477-9.
Score: 0.031
-
Staples AO, Wong CS, Smith JM, Gipson DS, Filler G, Warady BA, Martz K, Greenbaum LA. Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol. 2009 Jan; 4(1):48-56.
Score: 0.021
-
Neu AM, Fivush BA, Warady BA, Watkins SL, Friedman AL, Brem AS, Goldstein S, Frankenfield DL. Longitudinal analysis of intermediate outcomes in adolescent hemodialysis patients. Pediatr Nephrol. 2003 Nov; 18(11):1172-6.
Score: 0.015
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|